Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Angelo Biotechnology Corporation is a high-tech enterprise specializing in the research, development, and industrial-scale production of functional proteases, specifically Superoxide Dismutase (SOD) and Nicotinamide Phosphoribosyltransferase (NAMPT). The company leverages its proprietary SOD·NAMPT double-chain protein extraction technology to develop a range of anti-aging, cardiovascular, and immune-supportive products. Operating globally with a significant presence in China, the United States, and Africa, Angelo Biotech integrates scientific research with a direct sales business model to distribute its nutraceutical and personal care solutions. Its product portfolio includes specialized dietary supplements like seabuckthorn oil capsules and feminine care granules, all centered on its core antioxidant and metabolic enzyme technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on All’Angelo.